Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate.
A patient with benign monoclonal IgG lambda paraproteinemia, acquired von Willebrand syndrome (AVWS), and chronic melena successfully responding to high-dose intravenous immunoglobulin (lvlg) is reported. Coagulation parameters at admission were APTT (ratio) 1.68; VIII:C 11 IU/dL; vWF:Ag 7 IU/dL:Ricof less than 3 IU/dl. RIPA was greater than 1.8 mg/ml, and bleeding time (BT) was prolonged (18 min). No evidence for an in vitro inhibitor against the VIII/vWF complex was observed. VIII/vWF measurements showed a short-lived increase after both DDAVP and Hemate P, and BT was transiently normalized. After intravenous Ig (1 g/kg for 2 days), VIII/vWF measurements, hemostatic parameters and multimeric pattern were completely corrected (VIII/C 106 IU/dl, vWF:Ag 168 IU/dl, RiCof 147 IU/dl, APTT ratio 0.89, BT 5'), with a return to pre-infusion values after 15 days. Hemoccult test became negative and packed red cell transfusions, of which 130 units were administered during the last year, were no longer required. After 18 months the patient is on maintenance treatment with repeated courses of Ig, at 3 to 4-week intervals based on VIII/vWF and BT monitoring.
Castaman
G
G
Department of Hematology, San Bortolo Hospital, Vicenza, Italy.
Tosetto
A
A
Rodeghiero
F
F
D001760:Bleeding Time; D002908:Chronic Disease; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005169:Factor VIII / Q000032:analysis / Q000627:therapeutic use*; D006801:Humans; D007122:Immunoelectrophoresis; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008551:Melena / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D010265:Paraproteinemias / Q000150:complications / Q000188:drug therapy; D014842:von Willebrand Diseases / Q000150:complications / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000032:analysis
D016756:Immunoglobulins, Intravenous; D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin